Next Article in Journal
Prediction of True Circulatory Decompensation in Chronic Heart Failure for Optimal Timing of Mechanical Circulatory Support: Non-Invasive Arterial-Ventricular Coupling
Previous Article in Journal
Monodisperse 130 kDa and 260 kDa Recombinant Human Hemoglobin Polymers as Scaffolds for Protein Engineering of Hemoglobin-Based Oxygen Carriers
Open AccessReview

Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties

Dipartimento di Scienze del Farmaco, Università degli Studi di Catania, viale A. Doria 6, Catania I-95125, Italy
*
Author to whom correspondence should be addressed.
J. Funct. Biomater. 2012, 3(1), 79-99; https://doi.org/10.3390/jfb3010079
Received: 15 December 2011 / Revised: 10 January 2012 / Accepted: 11 January 2012 / Published: 19 January 2012
Bone-seeking (osteotropic) drug delivery systems (ODDS) represent an interesting solution for targeting different types of drugs to the bones. In particular, anticancer and antibacterial agents could take advantage of such therapeutic strategy. We have recently developed an innovative approach to this aim: a new osteotropic biomaterial was prepared, based on the conjugation of a poly(lactide-co-glycolide) (PLGA) with the bisphosphonate drug alendronate (PLGA-ALE); its hemo- and cytocompatibility were verified. Starting with this copolymer, an osteotropic nanoparticle system (NP) was produced for the targeted delivery of antineoplastic drugs to osteolytic bone metastases; in particular, doxorubicin was tested as a model drug. The in vitro and in vivo results of the new ODDS are validated in this article. All the experimental data confirmed that the drug retained its activity after loading in the PLGA-ALE NP; they can be thus considered a new promising strategy for active targeting of drugs to bone tissues in different pathological situations. View Full-Text
Keywords: PLGA; alendronate; bone-seeking polymer; nanoparticles; biocompatibility; hemocompatibility; doxorubicin; osteolytic tumors; bone metastasis PLGA; alendronate; bone-seeking polymer; nanoparticles; biocompatibility; hemocompatibility; doxorubicin; osteolytic tumors; bone metastasis
Show Figures

Figure 1

MDPI and ACS Style

Pignatello, R.; Sarpietro, M.G.; Castelli, F. Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties. J. Funct. Biomater. 2012, 3, 79-99. https://doi.org/10.3390/jfb3010079

AMA Style

Pignatello R, Sarpietro MG, Castelli F. Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties. Journal of Functional Biomaterials. 2012; 3(1):79-99. https://doi.org/10.3390/jfb3010079

Chicago/Turabian Style

Pignatello, Rosario; Sarpietro, Maria Grazia; Castelli, Francesco. 2012. "Synthesis and Biological Evaluation of a New Polymeric Conjugate and Nanocarrier with Osteotropic Properties" J. Funct. Biomater. 3, no. 1: 79-99. https://doi.org/10.3390/jfb3010079

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop